Johnson & Johnson vs. Phathom Pharmaceuticals, Inc. Common Stock
JNJ
Johnson & Johnson
$266.30 +0.94%
VS PHATPhathom Pharmaceuticals, Inc. Common Stock
$5.94 +3.48%
Johnson & Johnson and Phathom Pharmaceuticals, Inc. Common Stock are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| JNJ | PHAT | |
|---|---|---|
| Market Cap | $635.07 billion | $464.37 million |
JNJ leads on 1 of 1 size & scale factors.
Dividend
| JNJ | PHAT | |
|---|---|---|
| Dividend Yield | 2.01% | — |
JNJ and PHAT split the dividend factors evenly.
Risk & Sentiment
| JNJ | PHAT | |
|---|---|---|
| Short Interest | 0.67% | 0.01% |
PHAT leads on 1 of 1 risk & sentiment factors.
Dig deeper: JNJ overview, JNJ financials, PHAT overview, PHAT financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.